Advanced in Langerhans Cell Histiocytosis
Advanced in Langerhans Cell Histiocytosis
Stc Pediatrics LLC
300 E Hunting Park Ave, St Christophers Ped Assoc, 
Philadelphia, PA 

Overview

Gregory Halligan is a Pediatrics specialist and a Hematologist in Philadelphia, Pennsylvania. Dr. Halligan is rated as an Advanced provider by MediFind in the treatment of Langerhans Cell Histiocytosis. His top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Rhabdomyosarcoma, Neuroblastoma, and Ewing Sarcoma.

His clinical research consists of co-authoring 7 peer reviewed articles and participating in 35 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has participated in 3 clinical trials in the study of Langerhans Cell Histiocytosis.

Specialties
Pediatrics
Hematology
Oncology
Licenses
Specialist in PA
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Avalon Health Care
  • MEDICARE PDP
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Gateway Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • OTHER MEDICARE PART D
Geisinger
  • HMO
  • POS
  • PPO
Health Partners Plans
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 12 Less Insurance Carriers -

Locations

STC PEDIATRICS LLC
300 E Hunting Park Ave, St Christophers Ped Assoc, Philadelphia, PA 19124
Other Locations
STC PEDIATRICS LLC
160 E Erie Ave, Philadelphia, PA 19134

Additional Areas of Focus

Dr. Halligan has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Neurofibromatosis Type 1 (NF1)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


35 Clinical Trials

A Phase 2 Study of Reduced Therapy for Newly Diagnosed Average-Risk WNT-Driven Medulloblastoma Patients
Pediatric Hepatic Malignancy International Therapeutic Trial (PHITT)
Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients With Non-High-Risk Neuroblastoma
A Phase III Randomized Trial Investigating Bortezomib (NSC# 681239) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T-Lymphoblastic Leukemia (T-ALL) and T-Lymphoblastic Lymphoma (T-LLy)
Randomized Phase 3 Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC# 750008) to Multiagent Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma
Risk-Stratified Randomized Phase III Testing of Blinatumomab (NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)
A Randomized Phase 3 Study of Brentuximab Vedotin (SGN-35) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Young Adults
A Phase III Randomized Trial for Newly Diagnosed High Risk B-Lymphoblastic Leukemia (B-ALL) Including a Stratum Evaluating Dasatinib (NSC#732517) in Patients With Ph-like Tyrosine Kinase Inhibitor (TKI) Sensitive Mutations
Treatment of Children With All Stages of Hepatoblastoma With Temsirolimus (NSC#683864) Added to High Risk Stratum Treatment
A Phase 3 Trial Investigating Blinatumomab (NSC# 765986) in Combination With Chemotherapy in Patients With Newly Diagnosed Standard Risk or Down Syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients With Localized B-Lymphoblastic Lymphoma (B-LLy)
Neuroblastoma Biology Studies
Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients With Newly Diagnosed Ependymoma Ages 1 to 21 Years
International Phase 3 Trial in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ALL) Testing Imatinib in Combination With Two Different Cytotoxic Chemotherapy Backbones
Risk-Stratified Therapy for Acute Myeloid Leukemia in Down Syndrome
Renal Tumors Classification, Biology, and Banking Study
A Groupwide Pilot Study to Test the Tolerability and Biologic Activity of the Addition of Azacitidine (IND# 133688, NSC# 102816) to Chemotherapy in Infants With Acute Lymphoblastic Leukemia (ALL) and KMT2A(MLL) Gene Rearrangement
A Phase III Study for Patients With Newly Diagnosed Acute Promyelocytic Leukemia (APL) Using Arsenic Trioxide and All-Trans Retinoic Acid
View 34 Less Clinical Trials
Similar Doctors
Advanced in Langerhans Cell Histiocytosis
Advanced in Langerhans Cell Histiocytosis

Abramson Cancer Center Perelman 4th Floor West

3400 Civic Center Boulevard, West Pavilion, 4th Floor, 
Philadelphia, PA 
 (5.9 miles away)
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Sunita Nasta is a Hematologist in Philadelphia, Pennsylvania. Dr. Nasta is rated as an Elite provider by MediFind in the treatment of Langerhans Cell Histiocytosis. Her top areas of expertise are Non-Hodgkin Lymphoma, B-Cell Lymphoma, Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Nasta is currently accepting new patients.

Jacob A. Troutman
Experienced in Langerhans Cell Histiocytosis
Hematology | Oncology
Experienced in Langerhans Cell Histiocytosis
Hematology | Oncology

LVPG Pediatric Hematology Oncology-Cedar Crest

1210 S Cedar Crest Blvd., Suite 1000, 
Allentown, PA 
 (43.7 miles away)
Experience:
17+ years
Languages Spoken:
English

Philosophy of care | I believe children are a unique population of patients that require a physician dedicated to their well-being. I believe they are vulnerable and often unable to speak up for themselves. I believe that each child and family should be treated as if they are my own relation. | Why I entered medicine | I entered medicine for the satisfaction of being able to help and offer hope to those who are ill. I chose pediatric hematology oncology because these children have a serious illness and their parents are at the lowest point of their lives, and I can provide them with hope and compassion. | Community involvement | I volunteer at Camp Dost, a camp for children with cancer. Since 2003 I have helped there, and love seeing how this experience helps kids who are dealing with cancer enjoy time just being kids. | Personal interests | I enjoy many types of sports, but specifically like basketball, baseball, football, and golf. I also like to go canoeing and doing physical fitness activities. Dr. Troutman is rated as an Advanced provider by MediFind in the treatment of Langerhans Cell Histiocytosis. His top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Sickle Cell Disease, Thalassemia, and Hemoglobin SC Disease.

Experienced in Langerhans Cell Histiocytosis
Hematology Oncology | Hematology | Oncology
Experienced in Langerhans Cell Histiocytosis
Hematology Oncology | Hematology | Oncology
3 Cooper Plz, Suite 215, 
Camden, NJ 
 (4.9 miles away)
Languages Spoken:
English

Nati Lerman is a Hematologist Oncology specialist and a Hematologist in Camden, New Jersey. Dr. Lerman is rated as a Distinguished provider by MediFind in the treatment of Langerhans Cell Histiocytosis. His top areas of expertise are Embryonal Tumor with Multilayered Rosettes, Astrocytoma, Posterior Fossa Tumor, and Neuroepithelioma.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Halligan's expertise for a condition
ConditionClose
      View All 61 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile